Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Portable Nucleic Acid Extraction System Developed For POC Diagnostics

By LabMedica International staff writers
Posted on 31 Jul 2013
A portable, pressure driven, room temperature nucleic acid extraction and storage system for point of care (POC) molecular diagnostics has been developed. More...


A minimally instrumented sample preparation technology yields a purified and thermally stabilized nucleic acid sample that eliminates the cold chain without reducing sensitivity or an increase in downstream processing infrastructure.

Biomedical engineers at Boston University (MA, USA) have developed a whole blood compatible, enzyme-free, ambient temperature, low-pressure nucleic acid extraction process that enables the creation of a completely powerless nucleic acid sample preparation technology. This technology will allow, for example human immunodeficiency virus (HIV) viral load monitoring in low resource areas.

A novel hybrid alcohol precipitation and solid phase extraction process has been presented, utilizing glycogen carrier particles to increase the effective hydrodynamic radius of precipitated nucleic acids aggregates, and a thermally polymerized acrylate based solid phase as a weir for analyte capture. An air pressure driven mechanical system was developed to perform this process in a semiautomated fashion, in order to insulate the process from variations in operator technique. Together, they form the System for Nucleic Acid Purification (SNAP).

The portable system for centrifuge-free room temperature nucleic acid extraction from 70 μL of whole blood uses only thermally stable reagents compatible with storage and transport in low resource settings. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis of simulated samples demonstrate a lower limit of detection of 1,000 copies per mL, with the ability to detect differences in viral load across four orders of magnitude.

The device weighs less than 1.36 kg and is capable of extracting HIV-1 viral ribonucleic acid (RNA) directly from virions in whole blood in less than 35 minutes. Samples are stabilized on detachable cartridges, which can be eluted either at the point of care, or transported to a centralized laboratory for further analysis. The study was published on May 13, 2013, in the journal Analytical Methods.

Related Links:

Boston University




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.